Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Staci D Arnold

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
British Journal of Haematology|June 4, 2016
Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approachesStaci D Arnold, Monica Bhatia, John Horan, et al.
Pediatric Radiology|June 22, 2016
Imaging findings in a child with calcineurin inhibitor-induced pain syndrome after bone marrow transplant for beta thalassemia majorRama S Ayyala, Staci D Arnold, Monica Bhatia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 24, 2015
Allogeneic Hematopoietic Cell Transplantation for Children with Sickle Cell Disease Is Beneficial and Cost-Effective: A Single-Center AnalysisStaci D Arnold, Zhezhen Jin, Stephen Sands, et al.
Transplantation and Cellular Therapy|April 10, 2021
A Qualitative Analysis of State Medicaid Coverage Benefits for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Sickle Cell Disease (SCD)Tatenda G Mupfudze, Jaime M Preussler, Jennifer A Sees, et al.
Transplantation and Cellular Therapy|May 11, 2023
Female Reproductive Health Outcomes after Hematopoietic Cell Transplantation for Sickle Cell Disease: Is Reduced Intensity Better Than Myeloablative Conditioning?Lillian R Meacham, Sobenna George, Anirudh Veludhandi, et al.
Transplantation and Cellular Therapy|April 25, 2021
Hematopoietic Cell Transplantation Outcomes among Medicaid and Privately Insured Patients with Sickle Cell DiseaseTatenda G Mupfudze, Christa Meyer, Jaime M Preussler, et al.
Annals of Internal Medicine|January 22, 2024
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness AnalysisAnirban Basu, Aaron N Winn, Kate M Johnson, et al.
Infection Control and Hospital Epidemiology|May 9, 2018
Hospital-Level Variability in Broad-Spectrum Antibiotic Use for Children With Acute Leukemia Undergoing Hematopoietic Cell TransplantationCaitlin W Elgarten, Staci D Arnold, Yimei Li, et al.
Neuro-Oncology|March 4, 2008
Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumorsStaci D Arnold, Leslie M Forman, Bart D Brigidi, et al.
JAMA Pediatrics|September 12, 2017
Association of Guideline-Adherent Antibiotic Treatment With Readmission of Children With Sickle Cell Disease Hospitalized With Acute Chest SyndromeDavid G Bundy, Troy E Richardson, Matthew Hall, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|June 4, 2016
Haematopoietic stem cell transplantation for sickle cell disease - current practice and new approachesStaci D Arnold, Monica Bhatia, John Horan, et al.
Pediatric Radiology|June 22, 2016
Imaging findings in a child with calcineurin inhibitor-induced pain syndrome after bone marrow transplant for beta thalassemia majorRama S Ayyala, Staci D Arnold, Monica Bhatia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 24, 2015
Allogeneic Hematopoietic Cell Transplantation for Children with Sickle Cell Disease Is Beneficial and Cost-Effective: A Single-Center AnalysisStaci D Arnold, Zhezhen Jin, Stephen Sands, et al.
Transplantation and Cellular Therapy|April 10, 2021
A Qualitative Analysis of State Medicaid Coverage Benefits for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Sickle Cell Disease (SCD)Tatenda G Mupfudze, Jaime M Preussler, Jennifer A Sees, et al.
Transplantation and Cellular Therapy|May 11, 2023
Female Reproductive Health Outcomes after Hematopoietic Cell Transplantation for Sickle Cell Disease: Is Reduced Intensity Better Than Myeloablative Conditioning?Lillian R Meacham, Sobenna George, Anirudh Veludhandi, et al.
Transplantation and Cellular Therapy|April 25, 2021
Hematopoietic Cell Transplantation Outcomes among Medicaid and Privately Insured Patients with Sickle Cell DiseaseTatenda G Mupfudze, Christa Meyer, Jaime M Preussler, et al.
Annals of Internal Medicine|January 22, 2024
Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness AnalysisAnirban Basu, Aaron N Winn, Kate M Johnson, et al.
Infection Control and Hospital Epidemiology|May 9, 2018
Hospital-Level Variability in Broad-Spectrum Antibiotic Use for Children With Acute Leukemia Undergoing Hematopoietic Cell TransplantationCaitlin W Elgarten, Staci D Arnold, Yimei Li, et al.
Neuro-Oncology|March 4, 2008
Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumorsStaci D Arnold, Leslie M Forman, Bart D Brigidi, et al.
JAMA Pediatrics|September 12, 2017
Association of Guideline-Adherent Antibiotic Treatment With Readmission of Children With Sickle Cell Disease Hospitalized With Acute Chest SyndromeDavid G Bundy, Troy E Richardson, Matthew Hall, et al.
Pageof 4